Human papillomavirus E7 protein induces homologous recombination defects and PARPi sensitivity.

Authors:
He S; Wang A; Wang J; Tang Z; Wang X and 6 more

Journal:
J Cancer Res Clin Oncol

Publication Year: 2024

DOI:
10.1007/s00432-023-05511-6

PMCID:
PMC10805821

PMID:
38263342

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Cancer Res Clin Oncol

Abbreviation: J Cancer Res Clin Oncol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Neoplasms

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Advances in the antitumor mechanisms of tripartite motif-containing protein 3.
Teng W; Ling Y; Liu Z and 6 more (2024) - Transparency Score: 3/6
A novel EIF3C-related CD8<sup>+</sup> T-cell signature in predicting prognosis and immunotherapy re…
Li R; Wang Y; Wen X and 10 more (2024) - Transparency Score: 4/6
An update of predictive biomarkers related to WEE1 inhibition in cancer therapy.
Wang Z; Li W; Li F and 1 more (2024) - Transparency Score: 3/6
Approved immune checkpoint inhibitors in hepatocellular carcinoma: a large-scale meta-analysis and …
Zhang R; Wang F; You Z and 6 more (2024) - Transparency Score: 3/6
A rare Ewing-like small round cell tumor in prostate: a case report and literature review.
Wang Z; Ye J; Hu J and 2 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Competing interestsThe authors declare no competing interests. Ethical approvalDe-identified cervical materials were collected from patients in agreement with institutional ethical regulations. Informed consent was provided via protocol (Medical Research 2021(056)) approved by the ethical committees of West China Second University Hospital. Competing interests The authors declare no competing interests."

Evidence found in paper:

"This work is supported by the National Natural Science Foundation of China (81821002), Sichuan University (2020SCUNL204, SCU2019C4198, and 22H0851), Department of Science and Technology of Sichuan Province (2019JDTD0020, 2020YFH0019, 2022NSFSC1502, and 2023NSFSC0738)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025